Alzheimer Check-up

A specialist memory and cognitive health programme combining cranial MRI with volumetric brain analysis, neuropsychological assessment led by a psychologist, neurological evaluation, and supporting blood and urine tests. Designed for early detection of cognitive decline and neurodegenerative conditions.

Cognitive decline associated with Alzheimer's disease and related conditions often begins years before noticeable symptoms affect daily life. This programme is structured to detect early changes through complementary neurological, neuropsychological, and imaging investigations. The cranial MRI includes a volumetric study that measures the size of specific brain structures — particularly the hippocampus and cortical regions — that are known to atrophy in the early stages of neurodegenerative disease. Comparing volumes against age-matched normative data can identify shrinkage patterns that precede clinical symptoms. CreuBlanca's 3 Tesla MRI equipment provides the resolution needed for accurate volumetric measurements. The neuropsychological assessment is conducted by a psychologist using standardised cognitive testing protocols. This evaluation maps performance across memory, attention, executive function, language, and visuospatial domains, identifying subtle deficits that may not be apparent in everyday functioning. The neurological evaluation adds a clinical assessment of reflexes, coordination, and neurological signs. Blood and urine analysis helps rule out reversible causes of cognitive symptoms — thyroid dysfunction, vitamin deficiencies, metabolic abnormalities, and infections can all mimic or exacerbate cognitive decline. The programme produces a multi-dimensional picture that distinguishes between normal age-related changes, reversible causes of cognitive difficulty, and patterns suggestive of early neurodegeneration.